

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.25042522 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 4.00968657 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.00968657 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.00968657 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.00968657 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.00968657 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.00968657 |
| 8 | response to peptidoglycan (GO:0032494) | 3.88142665 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77949457 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57290041 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 3.48298283 |
| 12 | detection of other organism (GO:0098543) | 3.20281321 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.19980816 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18271791 |
| 15 | B cell mediated immunity (GO:0019724) | 3.18200309 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15282485 |
| 17 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14385273 |
| 18 | response to host immune response (GO:0052572) | 3.14295410 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14295410 |
| 20 | detection of bacterium (GO:0016045) | 3.06684033 |
| 21 | pinocytosis (GO:0006907) | 2.96894705 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96642288 |
| 23 | negative regulation of cell killing (GO:0031342) | 2.96642288 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96010713 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 2.94847813 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91817744 |
| 27 | response to host (GO:0075136) | 2.88484523 |
| 28 | response to host defenses (GO:0052200) | 2.88484523 |
| 29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88484523 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 2.83944765 |
| 31 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.80055059 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 2.77719189 |
| 33 | detection of external biotic stimulus (GO:0098581) | 2.77709191 |
| 34 | neutrophil activation (GO:0042119) | 2.76564749 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 2.73945578 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.71549095 |
| 37 | cellular response to type I interferon (GO:0071357) | 2.71472364 |
| 38 | type I interferon signaling pathway (GO:0060337) | 2.71472364 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 2.69232503 |
| 40 | pentose-phosphate shunt (GO:0006098) | 2.67839270 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67144435 |
| 42 | response to type I interferon (GO:0034340) | 2.66934270 |
| 43 | granulocyte activation (GO:0036230) | 2.65796872 |
| 44 | regulation of superoxide anion generation (GO:0032928) | 2.59562483 |
| 45 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59198775 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.59037314 |
| 47 | cellular extravasation (GO:0045123) | 2.57294725 |
| 48 | NADPH regeneration (GO:0006740) | 2.55427370 |
| 49 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54332576 |
| 50 | NIK/NF-kappaB signaling (GO:0038061) | 2.54021913 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50205487 |
| 52 | positive regulation of interferon-alpha production (GO:0032727) | 2.48938917 |
| 53 | response to interferon-beta (GO:0035456) | 2.47349145 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.44505725 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.42987158 |
| 56 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.42333234 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.39467613 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.39431011 |
| 59 | regulation of interferon-alpha production (GO:0032647) | 2.38556265 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 2.36123618 |
| 61 | respiratory burst (GO:0045730) | 2.34574353 |
| 62 | positive regulation of macrophage differentiation (GO:0045651) | 2.34284370 |
| 63 | detection of biotic stimulus (GO:0009595) | 2.34171804 |
| 64 | leukocyte degranulation (GO:0043299) | 2.33903003 |
| 65 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33685568 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.31623349 |
| 67 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.31392966 |
| 68 | regulation of B cell apoptotic process (GO:0002902) | 2.31279622 |
| 69 | pentose metabolic process (GO:0019321) | 2.30683638 |
| 70 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.30458000 |
| 71 | negative regulation of innate immune response (GO:0045824) | 2.30187873 |
| 72 | amino sugar catabolic process (GO:0046348) | 2.29580375 |
| 73 | regulation of leukocyte degranulation (GO:0043300) | 2.29542240 |
| 74 | defense response to protozoan (GO:0042832) | 2.29409607 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.28793478 |
| 76 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.28547372 |
| 77 | negative regulation of B cell apoptotic process (GO:0002903) | 2.27978598 |
| 78 | mitochondrial calcium ion transport (GO:0006851) | 2.27972971 |
| 79 | response to muramyl dipeptide (GO:0032495) | 2.26837693 |
| 80 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.26235889 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.25823431 |
| 82 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.24705110 |
| 83 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.23910809 |
| 84 | regulation of B cell differentiation (GO:0045577) | 2.23590610 |
| 85 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.22571124 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.21838677 |
| 87 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.21394806 |
| 88 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.21224415 |
| 89 | positive regulation of mast cell activation (GO:0033005) | 2.20803450 |
| 90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.20459273 |
| 91 | cellular response to interferon-beta (GO:0035458) | 2.20321892 |
| 92 | protein maturation by protein folding (GO:0022417) | 2.17964445 |
| 93 | response to protozoan (GO:0001562) | 2.17784303 |
| 94 | positive regulation of interferon-beta production (GO:0032728) | 2.17291913 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.16987458 |
| 96 | positive regulation of interleukin-10 production (GO:0032733) | 2.16427139 |
| 97 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.15953731 |
| 98 | purine nucleotide salvage (GO:0032261) | 2.15398968 |
| 99 | cell wall macromolecule catabolic process (GO:0016998) | 2.15025456 |
| 100 | cellular response to arsenic-containing substance (GO:0071243) | 2.14886505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.74841486 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.00204090 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60846885 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41892993 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.27207537 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21880225 |
| 7 | * MYC_22102868_ChIP-Seq_BL_Human | 2.20185966 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.15141625 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14513566 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14346536 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.08865946 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06562804 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02775061 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99610793 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.97310075 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.92377573 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92362555 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89175583 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.88057966 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87755628 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87214635 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85356411 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.80837189 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78360966 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78019910 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76716572 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76003326 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.69768011 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68876716 |
| 30 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67797449 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67758445 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64920345 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.63403090 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61641503 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.60225540 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58823226 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.58273115 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56162604 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54283270 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.53664459 |
| 41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.50326268 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47413049 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45592059 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44745291 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43786253 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43628079 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.43514692 |
| 48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43257809 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43089187 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43051899 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41753769 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.41022406 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40506192 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.40064658 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.39075785 |
| 56 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38275896 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.37843672 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37190685 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34826571 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.34675824 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33798024 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33692061 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.33349590 |
| 64 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.32531382 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32405435 |
| 66 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.31080808 |
| 67 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29658718 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28953361 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28840054 |
| 70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27747401 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.27627060 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27256103 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26000987 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25883513 |
| 75 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24495503 |
| 76 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23043016 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22265438 |
| 78 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.19462335 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18491453 |
| 80 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17801935 |
| 81 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.17656704 |
| 82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17266129 |
| 83 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17085526 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16782588 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16398407 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14809772 |
| 87 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12654666 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12236063 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11087034 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10392176 |
| 91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10049765 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09376747 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09227482 |
| 94 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09020587 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08812841 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08764568 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08573709 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08000043 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06634037 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06616472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 3.29413166 |
| 2 | MP0003724_increased_susceptibility_to | 2.99184622 |
| 3 | MP0003303_peritoneal_inflammation | 2.98225655 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.95733552 |
| 5 | MP0008260_abnormal_autophagy | 2.75041190 |
| 6 | MP0003436_decreased_susceptibility_to | 2.74707589 |
| 7 | MP0005451_abnormal_body_composition | 2.65765078 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.63498455 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.28353761 |
| 10 | MP0002419_abnormal_innate_immunity | 2.23032811 |
| 11 | MP0002132_abnormal_respiratory_system | 2.18702843 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.17506816 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.11023431 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.06312526 |
| 15 | MP0005671_abnormal_response_to | 2.05986321 |
| 16 | MP0005025_abnormal_response_to | 2.05592281 |
| 17 | MP0000685_abnormal_immune_system | 2.05447191 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.03902560 |
| 19 | MP0001800_abnormal_humoral_immune | 2.01078707 |
| 20 | MP0009785_altered_susceptibility_to | 2.00410447 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.00047496 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.95643708 |
| 23 | MP0002723_abnormal_immune_serum | 1.93895145 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.90898930 |
| 25 | MP0009278_abnormal_bone_marrow | 1.88645946 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.84738212 |
| 27 | MP0002398_abnormal_bone_marrow | 1.83622805 |
| 28 | MP0001819_abnormal_immune_cell | 1.83551515 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.77416509 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.77416509 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.77131119 |
| 32 | MP0001790_abnormal_immune_system | 1.74400375 |
| 33 | MP0005387_immune_system_phenotype | 1.74400375 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.73656999 |
| 35 | MP0009840_abnormal_foam_cell | 1.66843383 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.63661047 |
| 37 | MP0000716_abnormal_immune_system | 1.59845266 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.56128368 |
| 39 | MP0002722_abnormal_immune_system | 1.55323930 |
| 40 | MP0002429_abnormal_blood_cell | 1.54866344 |
| 41 | MP0000858_altered_metastatic_potential | 1.52083106 |
| 42 | MP0003111_abnormal_nucleus_morphology | 1.47853032 |
| 43 | MP0004947_skin_inflammation | 1.46757548 |
| 44 | MP0001853_heart_inflammation | 1.43487861 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.40903269 |
| 46 | MP0002405_respiratory_system_inflammati | 1.40761738 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.39500126 |
| 48 | MP0008004_abnormal_stomach_pH | 1.39079291 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.37808019 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.34621429 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.34036060 |
| 52 | MP0009764_decreased_sensitivity_to | 1.32378081 |
| 53 | MP0008469_abnormal_protein_level | 1.31830143 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.31391446 |
| 55 | MP0006082_CNS_inflammation | 1.30890814 |
| 56 | MP0004381_abnormal_hair_follicle | 1.27995238 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.26854398 |
| 58 | MP0008057_abnormal_DNA_replication | 1.25525167 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.22041235 |
| 60 | MP0003693_abnormal_embryo_hatching | 1.21505896 |
| 61 | MP0003186_abnormal_redox_activity | 1.20777482 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.19182775 |
| 63 | MP0003077_abnormal_cell_cycle | 1.17227718 |
| 64 | MP0000343_altered_response_to | 1.14930658 |
| 65 | MP0004510_myositis | 1.13773130 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 1.12742133 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.09654276 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.08218113 |
| 69 | MP0000490_abnormal_crypts_of | 1.06742975 |
| 70 | MP0009763_increased_sensitivity_to | 1.03297507 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 1.02324402 |
| 72 | MP0003075_altered_response_to | 0.99624988 |
| 73 | MP0000313_abnormal_cell_death | 0.97126695 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 0.96973321 |
| 75 | MP0003866_abnormal_defecation | 0.96325500 |
| 76 | MP0001851_eye_inflammation | 0.95131928 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.91454627 |
| 78 | MP0003828_pulmonary_edema | 0.91288832 |
| 79 | MP0008058_abnormal_DNA_repair | 0.90730368 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.90562755 |
| 81 | MP0003786_premature_aging | 0.90239803 |
| 82 | MP0008007_abnormal_cellular_replicative | 0.85861685 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.84588986 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.82398158 |
| 85 | MP0000609_abnormal_liver_physiology | 0.81063764 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79879846 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.79788343 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.79408488 |
| 89 | MP0005310_abnormal_salivary_gland | 0.79370604 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.78981837 |
| 91 | MP0001661_extended_life_span | 0.78169349 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.77599136 |
| 93 | MP0000350_abnormal_cell_proliferation | 0.77176380 |
| 94 | MP0001730_embryonic_growth_arrest | 0.76912190 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.76445514 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.76102845 |
| 97 | MP0000358_abnormal_cell_content/ | 0.75966720 |
| 98 | MP0000598_abnormal_liver_morphology | 0.73763968 |
| 99 | MP0001764_abnormal_homeostasis | 0.73324731 |
| 100 | MP0005621_abnormal_cell_physiology | 0.73157733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 4.82450134 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.31383177 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.18859617 |
| 4 | Prolonged bleeding time (HP:0003010) | 4.12884599 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.06938258 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.91007132 |
| 7 | Purpura (HP:0000979) | 3.78548613 |
| 8 | Gingival bleeding (HP:0000225) | 3.63529106 |
| 9 | Epistaxis (HP:0000421) | 3.61736926 |
| 10 | Obstructive lung disease (HP:0006536) | 3.46231149 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.46231149 |
| 12 | Abnormal platelet volume (HP:0011876) | 3.27248887 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.22974420 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.06353227 |
| 15 | Hepatosplenomegaly (HP:0001433) | 3.00964195 |
| 16 | Myositis (HP:0100614) | 2.98059262 |
| 17 | Increased mean platelet volume (HP:0011877) | 2.97125617 |
| 18 | Menorrhagia (HP:0000132) | 2.90479457 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.90110338 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 2.85944733 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.85944733 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.85944733 |
| 23 | Orchitis (HP:0100796) | 2.84306351 |
| 24 | Recurrent viral infections (HP:0004429) | 2.82622802 |
| 25 | Stomatitis (HP:0010280) | 2.77840869 |
| 26 | Impaired platelet aggregation (HP:0003540) | 2.75732529 |
| 27 | Abnormal platelet function (HP:0011869) | 2.75732529 |
| 28 | Meningitis (HP:0001287) | 2.74689809 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.73546634 |
| 30 | Recurrent skin infections (HP:0001581) | 2.71093806 |
| 31 | Colitis (HP:0002583) | 2.70337312 |
| 32 | Acute hepatic failure (HP:0006554) | 2.67716059 |
| 33 | Urticaria (HP:0001025) | 2.63630795 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.61260873 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60204925 |
| 36 | Increased IgM level (HP:0003496) | 2.60140818 |
| 37 | Increased serum ferritin (HP:0003281) | 2.57464528 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54099713 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 2.52698645 |
| 40 | Cellulitis (HP:0100658) | 2.49771232 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.48215948 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46323730 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46323730 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.44739652 |
| 45 | Optic neuritis (HP:0100653) | 2.44739652 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.44156966 |
| 47 | Encephalitis (HP:0002383) | 2.42401754 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.39238841 |
| 49 | Vasculitis (HP:0002633) | 2.38641180 |
| 50 | Anorexia (HP:0002039) | 2.37463736 |
| 51 | Hypertensive crisis (HP:0100735) | 2.36404296 |
| 52 | Fatigue (HP:0012378) | 2.34615962 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.34455335 |
| 54 | Arterial thrombosis (HP:0004420) | 2.32243188 |
| 55 | Loss of speech (HP:0002371) | 2.31982786 |
| 56 | Abnormality of iron homeostasis (HP:0011031) | 2.31060707 |
| 57 | Ragged-red muscle fibers (HP:0003200) | 2.26783417 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.24217590 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.21619797 |
| 60 | Chest pain (HP:0100749) | 2.17627419 |
| 61 | IgM deficiency (HP:0002850) | 2.11877460 |
| 62 | Abnormality of T cells (HP:0002843) | 2.10953772 |
| 63 | Granulocytopenia (HP:0001913) | 2.10404546 |
| 64 | Progressive muscle weakness (HP:0003323) | 2.09994293 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.07487135 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07483398 |
| 67 | Increased IgE level (HP:0003212) | 2.04789980 |
| 68 | Osteomyelitis (HP:0002754) | 2.04071440 |
| 69 | Cholecystitis (HP:0001082) | 2.03665863 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.03665863 |
| 71 | Myocardial infarction (HP:0001658) | 2.01033478 |
| 72 | Pustule (HP:0200039) | 2.00907884 |
| 73 | Joint swelling (HP:0001386) | 2.00386724 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 1.99951449 |
| 75 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.98418646 |
| 76 | Viral hepatitis (HP:0006562) | 1.93849075 |
| 77 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93826380 |
| 78 | Gingivitis (HP:0000230) | 1.91919892 |
| 79 | Aplastic anemia (HP:0001915) | 1.90585620 |
| 80 | Prolonged neonatal jaundice (HP:0006579) | 1.88358259 |
| 81 | T lymphocytopenia (HP:0005403) | 1.87630113 |
| 82 | Progressive neurologic deterioration (HP:0002344) | 1.85438944 |
| 83 | Rough bone trabeculation (HP:0100670) | 1.84894675 |
| 84 | Amyloidosis (HP:0011034) | 1.83942651 |
| 85 | Nausea (HP:0002018) | 1.82158345 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 1.81921997 |
| 87 | Polycythemia (HP:0001901) | 1.81377162 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.80948498 |
| 89 | Thrombophlebitis (HP:0004418) | 1.80858864 |
| 90 | Paralysis (HP:0003470) | 1.78764093 |
| 91 | Skin rash (HP:0000988) | 1.78435340 |
| 92 | Splenomegaly (HP:0001744) | 1.77343472 |
| 93 | Leukocytosis (HP:0001974) | 1.77130978 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 1.76577361 |
| 95 | Seborrheic dermatitis (HP:0001051) | 1.76062173 |
| 96 | Abnormality of T cell number (HP:0011839) | 1.75944551 |
| 97 | Microvesicular hepatic steatosis (HP:0001414) | 1.75142143 |
| 98 | Skin ulcer (HP:0200042) | 1.74521178 |
| 99 | Amaurosis fugax (HP:0100576) | 1.74112533 |
| 100 | Dysostosis multiplex (HP:0000943) | 1.73391318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 3.19132187 |
| 2 | RIPK4 | 3.00215266 |
| 3 | NME2 | 2.84667844 |
| 4 | ERN1 | 2.68186277 |
| 5 | IRAK4 | 2.64386840 |
| 6 | MAP4K1 | 2.60334480 |
| 7 | BLK | 2.34422996 |
| 8 | IRAK3 | 2.30109728 |
| 9 | TESK2 | 2.26037224 |
| 10 | EIF2AK1 | 2.11723799 |
| 11 | TYK2 | 1.98798135 |
| 12 | BUB1 | 1.97273508 |
| 13 | MAP3K3 | 1.94636377 |
| 14 | MAP3K11 | 1.94578293 |
| 15 | SMG1 | 1.94144161 |
| 16 | TAOK2 | 1.66741136 |
| 17 | PRPF4B | 1.66350988 |
| 18 | JAK3 | 1.64485403 |
| 19 | TXK | 1.63737603 |
| 20 | TBK1 | 1.59309892 |
| 21 | STK10 | 1.58772752 |
| 22 | BTK | 1.52509521 |
| 23 | ZAP70 | 1.50993756 |
| 24 | MAP3K14 | 1.42841773 |
| 25 | GRK6 | 1.37838999 |
| 26 | FGR | 1.32275315 |
| 27 | TRIB3 | 1.29212181 |
| 28 | PIM2 | 1.27640479 |
| 29 | KDR | 1.27570157 |
| 30 | CSF1R | 1.23304468 |
| 31 | IKBKE | 1.21284246 |
| 32 | CSK | 1.20227228 |
| 33 | SYK | 1.17753467 |
| 34 | IKBKB | 1.15494737 |
| 35 | VRK2 | 1.14428938 |
| 36 | SCYL2 | 1.13649920 |
| 37 | BCKDK | 1.11462463 |
| 38 | EPHB1 | 1.09145935 |
| 39 | HCK | 1.08602222 |
| 40 | MAP3K1 | 1.08397815 |
| 41 | TAOK3 | 1.06778417 |
| 42 | FES | 1.06217303 |
| 43 | MAP3K8 | 1.05686563 |
| 44 | STK4 | 1.02978572 |
| 45 | TNK2 | 1.01353109 |
| 46 | MARK3 | 0.99008005 |
| 47 | LYN | 0.98543742 |
| 48 | PAK4 | 0.98458393 |
| 49 | SIK3 | 0.95761138 |
| 50 | CDK12 | 0.95541784 |
| 51 | IRAK1 | 0.94610330 |
| 52 | PBK | 0.94419481 |
| 53 | BMX | 0.93440228 |
| 54 | IRAK2 | 0.93397201 |
| 55 | JAK2 | 0.92676283 |
| 56 | MATK | 0.92333140 |
| 57 | TAOK1 | 0.85480270 |
| 58 | LRRK2 | 0.80774581 |
| 59 | SRPK1 | 0.79361226 |
| 60 | MAPK11 | 0.77866841 |
| 61 | MAP3K5 | 0.77275734 |
| 62 | CDK4 | 0.76608410 |
| 63 | MAP3K13 | 0.75133457 |
| 64 | MST4 | 0.73689960 |
| 65 | FGFR4 | 0.72813455 |
| 66 | RAF1 | 0.67415143 |
| 67 | PAK1 | 0.62599523 |
| 68 | PIM1 | 0.62129100 |
| 69 | STK16 | 0.61811534 |
| 70 | EIF2AK3 | 0.61723888 |
| 71 | CDK7 | 0.60310399 |
| 72 | SIK1 | 0.59833982 |
| 73 | CCNB1 | 0.56217863 |
| 74 | TGFBR2 | 0.55962315 |
| 75 | LCK | 0.54149531 |
| 76 | JAK1 | 0.53352975 |
| 77 | KSR2 | 0.52826423 |
| 78 | TEC | 0.52125356 |
| 79 | CDC7 | 0.51168636 |
| 80 | PRKD2 | 0.50691447 |
| 81 | AURKA | 0.49401790 |
| 82 | CLK1 | 0.49306347 |
| 83 | DAPK1 | 0.49007070 |
| 84 | RPS6KA4 | 0.48977171 |
| 85 | MAPKAPK2 | 0.46783792 |
| 86 | PIK3CG | 0.45768460 |
| 87 | KIT | 0.44841400 |
| 88 | ABL2 | 0.44658065 |
| 89 | HIPK2 | 0.44393049 |
| 90 | GRK7 | 0.44129173 |
| 91 | PDPK1 | 0.40554056 |
| 92 | PTK6 | 0.39579625 |
| 93 | ITK | 0.39540212 |
| 94 | ILK | 0.38546479 |
| 95 | RPS6KA5 | 0.38439670 |
| 96 | NME1 | 0.37478273 |
| 97 | CDK6 | 0.36875923 |
| 98 | ATR | 0.35950811 |
| 99 | BRSK2 | 0.34808722 |
| 100 | MOS | 0.34581226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.54285513 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.33030872 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.22594872 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05082409 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90596142 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 1.87423646 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 1.81727441 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79349000 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76849106 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 1.76728042 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70126507 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67851591 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63765179 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61113087 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59071435 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57097178 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.56313563 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54631473 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.50753594 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48378368 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.45951082 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.43386416 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39288577 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.38384913 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.34664583 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34048920 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33305140 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32632242 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31275814 |
| 30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.27637657 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26996152 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21427587 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.21361466 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20573357 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.18104740 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17739042 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.17252307 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16984707 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16573673 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16205029 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12162440 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11510725 |
| 43 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.10397120 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10232331 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.08328041 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.07822860 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06942603 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06345837 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05741369 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04468416 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04219713 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.03673669 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02138181 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01973090 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01498028 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99367831 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.98095437 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.97882128 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.97066303 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95686554 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.93700599 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.93292868 |
| 63 | Homologous recombination_Homo sapiens_hsa03440 | 0.91142733 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.90598628 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88041920 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86678412 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85944067 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84645315 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77977084 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.77185911 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76284029 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75198634 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73735466 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73655806 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72030545 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71777344 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71664635 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71458466 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69953093 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67401730 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.65976543 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64393464 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62577863 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.62162089 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.61943944 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61691853 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60095858 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.58692254 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55304861 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53888221 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53058296 |
| 92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51002208 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50926228 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50164757 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49891020 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49717937 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46667689 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43654307 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42286297 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41958279 |

